# Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face

> **NCT05900258** · PHASE4 · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 22 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Tirbanibulin

## Key facts

- **NCT ID:** NCT05900258
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-11
- **Primary completion:** 2023-11-13
- **Final completion:** 2023-11-13
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05900258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05900258, "Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05900258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*